NCT06300567

Brief Summary

Assessment of the outcome of patients not concluded fir cystic fibrosis, either symptomatic patients or asymptomatic children detected by newborn screening for cystic fibrosis. The aim is to identify patients potentially at risk of progressing to the clinical spectrum of cystic fibrosis

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started May 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
May 2024Nov 2026

First Submitted

Initial submission to the registry

March 2, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2026

Expected
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

2 years

First QC Date

March 2, 2024

Last Update Submit

March 7, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • lung Imaging

    abnormal lung Imaging score, assessing the area of the lung with bronchiectasis, bronchial wall thickening, mucus plug and air trapping

    within 3 months after visit

Secondary Outcomes (2)

  • lung infection

    within 2 weeks after visit

  • pancreatic function

    within 2 weeks after visit

Study Arms (1)

patients with unconcluded diagnosis for cystic fibrosis

1. symptomatic patientscarrying 2 variants of CFTR, including at least 1 non CF causing 2. patients not concluded at neonatal screening of Cystic Fibrosis

Other: data collection

Interventions

collection of data of generated by "real world" follow up

patients with unconcluded diagnosis for cystic fibrosis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

children of adults not concluded for the diagnosis of Cystic fibrosis

You may qualify if:

  • patients not concluded for the diagnosis of Cystic fibrosis either because of intermediate sweat test or because extensive genetic study has identified 2 vrainats at least 1 being not CF causing

You may not qualify if:

  • patients carrying 2 CF causing variants of the CFTR gene
  • patients carrying only 1 or no variants of CFTR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 2, 2024

First Posted

March 8, 2024

Study Start

May 1, 2024

Primary Completion

May 2, 2026

Study Completion (Estimated)

November 2, 2026

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share